PDF Cover

IV Tubing Sets And Accessories Market

The market for IV Tubing Sets And Accessories was estimated at $1.5 billion in 2025; it is anticipated to increase to $2.0 billion by 2030, with projections indicating growth to around $2.8 billion by 2035.

Report ID:DS1806032
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Other Healthcare
IV Tubing Sets And Accessories
Share
Report Summary
Market Data
Methodology
Table of Contents

Global IV Tubing Sets And Accessories Market Outlook

Revenue, 2025

$1.5B

Forecast, 2035

$2.8B

CAGR, 2026 - 2035

6.3%

The IV Tubing Sets And Accessories industry revenue is expected to be around $1.5 billion in 2026 and expected to showcase growth with 6.3% CAGR between 2026 and 2035. With the backdrop of expanding surgical volumes and the increasing burden of chronic and infectious diseases, IV Tubing Sets And Accessories have become a critical item in hospital IV supplies and for infusion therapy. This is due to a global shift in IV administration protocols to evidence based methods and ones standardised. With an increasing demand in the medical sector for IV delivery systems, the healthcare industry is in need of IV equipment that performs flawlessly. This is particularly important in emergency care and intensive care units. These devices are used in 67.9% of all applications either for peripheral IV infusion or central venous infusion, demonstrating their importance in both treatment and maintenance of health. In the year 2025, the sales for primary IV tubing sets reached approximately $0.66 billion, this demonstrates the strong position that primary IV tubing holds within the Iv Tubing Sets and Accessories product range and its continued use in acute care and home infusion therapy. Iv Tubing Sets and Accessories comprise a range of products including primary IV tubing, secondary IV sets, needleless connectors, stopcocks, filters, extension lines and IV fluid regulators. These products enable healthcare professionals to administer fluids, blood, nutrients and medication through IV lines in patients veins. Modern IV tubing sets often have several beneficial features. These include the use of materials that are biocompatible and free from DEHP. Tubing sets are also designed to withstand pressure without collapsing and they resist kinking. Additionally, IV systems allow for precise control of the flow rate. This group of IV administration sets have applications across a number of key sectors including chemotherapy, parenteral nutrition, central and peripheral IV infusion and critical care. Additionally IV anaesthesia is another region of use. There is growing demand for IV infusions from home and outpatient care, which in turn drives demand for IV accessories. The IV therapy sector is experiencing various market trends. Closed and needleless IV infusion systems, low adsorption and antimicrobial IV fluid line technologies are being increasingly adopted. There is also greater standardisation of IV products across hospitals. In addition, there is a preference for single use IV tubes which aid in infection control and reduce operating costs.

IV Tubing Sets And Accessories market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
IV Tubing Sets And Accessories Market Outlook

Market Key Insights

  • The IV therapy tubing sets and accessories sector is expected to grow from 1.5 billion USD in 2025 to 2.8 billion USD by 2035. The sector has achieved a compound annual growth rate of 6.3%, due to increasing demand for medical infusion therapy, pharmaceutical drug delivery systems and clinical nutrition products.

  • The industry is dominated by seven main players. B. Braun Medical and Baxter hold the largest market shares within the industry.

  • The US and German markets are anticipated to lead the IV Tubing Sets and Accessories industry in terms of revenue generation. By 2030, these two markets are expected to achieve growth rates ranging from 4.1 to 6 per cent annually.

  • The highest growth rates are expected to be observed in the emerging markets of India, Brazil and Mexico, with a Compound Annual Growth Rate between 7.2% and 8.7%.

  • Future investment into disposable IV tubing sets may be prompted by the industry due to existing growth rates of 6.3%. This is expected to be supported with $65 million by 2030.

  • Over the period 2025 2035, it is predicted that IV Tubing Sets and Accessories will increase by $1.3 billion. Central venous infusion and peripherally inserted central catheter line infusion are projected to be of particular interest in this market.

  • The IV tubing sets and accessories market will experience significant growth over the coming two decades due to an increase in the incidence of chronic conditions and because of the continuous advancements in infusion technology. By 2035, the IV tubing sets and accessories market is predicted to be 84% larger than it was in 2025.

iv tubing sets and accessories market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
IV Tubing Sets And Accessories - Country Share Analysis

Opportunities in the IV Tubing Sets And Accessories

Healthcare providers across Europe are concentrating on selecting IV tubing sets and infusion pump systems that are compatible to reduce errors with medicines. The growing demand for IV tubes is leading to increased sales of IV tube fittings and also associated products such as anti kinking IV tube fittings. The IV tubing accessories market is expected to grow from $0.25 billion in 2014 to $0.35 billion by 2030. Suppliers who develop IV tubing products which are compatible with existing IV pumps by collaborating with the pump manufacturers can secure multi year contracts.

Growth Opportunities in North America and Asia-Pacific

In North America, intravenous tubing and related items have a demand mainly driven by central venous infusion and PICC line treatments. The key driver behind this demand is in the medical sector, particularly for oncology patients and other patients who require high levels of care. Such patients often require long term intravenous therapy. Key region's for growth lie in hospital consumables with premium safety features such as needle free connectors and which also possess anti microbial properties. These goods align with health facility infection control policies as well as value based purchasing procedures used by health networks. With global brand and group purchasing organisation owned private label companies placing such intense pressure on suppliers, it is now essential for these suppliers to compete. This is through provision of clinical evidence, supply chains resilient to disruption and secure infusion equipment. The trend towards treating patients in a home setting and ambulatory care is becoming increasingly prominent in the region, as are the numbers of those using outpatient cancer treatment facilities. Complex infusion services are also seeing a greater level of reimbursement, which may benefit suppliers who are able to offer IV tube sets along with digital traceability and inventory tracking systems. Companies should focus on having a diverse range of products which can be used alongside central venous and PICC lines. They should also look into the cost effectiveness of their products to increase their chances of being selected by healthcare providers. Manufacturers should also look to work alongside larger healthcare providers to secure long term supply contracts.
Across Asia Pacific, IV tubing sets and accessories market development is mainly influenced by peripheral IV infusions. This can be attributed to rapid development in hospital infrastructure and an increase in surgical operations. Emerging markets also have more access to standard infusion treatments. Central venous and PICC applications are expanding from these tertiary care centres. The greatest possibilities in the field are IV infusion kits and other healthcare equipment which are made in large quantities and are also low cost. These products must offer a good level of quality and should be packaged and manufactured in line with the specific needs of the government and private healthcare businesses. The market in this sector is extremely fragmented with a number of different manufacturers, some of which are regional and others are domestic, all competing with one another by pricing goods low and also by making sure that products are relevant to the local region. This leads to foreign firms being forced to differentiate themselves through consistent quality, complying with local laws, training employees, and being a reliable supplier when there is a surge in demand. Key drivers of growth include a heightened awareness of hospital acquired infections, universal health care and government initiatives to increase critical care facilities, and the need for safety devices for intravenous fluids. Companies should diversify their product lines and focus on providing different products for different target markets by creating high, medium and low cost IV infusion kits. They should focus on selling high value products to clients in large cities through established businesses and manufacturers in these region's. This will increase sales to clients in urban regions.

Market Dynamics and Supply Chain

01

Driver: Increasing Cases of Chronic diseases, and The Growing Aging Population

The increase in cases of illnesses like diabetes and cancer that necessitate extended care has also led to a significant rise in demand for IV tubing sets and related accessories in recent times. Hospital. Requirements for intravenous nutrition, dosing medications and blood transfusions are also key factors fuelng growth, in this particular market sector. The rise in the worlds population has also led to a higher demand for IV tubing sets and related accessories due to their weakened immunity and increased vulnerability, to infections and diseases that often necessitate hospitalization and IV treatment. A factor driving the growth of the market.
The rise of infusion technologies has also greatly boosted the market for IV tubing sets and accessories. Improvements such as safety needle stick technology and features, like reflux valves and needle free connectors have also made these products more attractive and led to increased adoption rates.
02

Restraint: Stringent Regulatory Requirements

The market for IV tubing sets and accessories encounters challenges because of the strict regulatory procedures imposed by organizations such as the FDA and other global authorities on medical devices development and distribution processes. These regulatory bodies oversee every aspect from design, to commercialization. Often demand extensive clinical trials to guarantee the products safety and efficacy. As a result of these regulations reaching regulatory approval can be a lengthy and expensive process that may hinder market expansion.
03

Opportunity: Indian private hospital critical care expansion unlocks demand for advanced Iv Tubing Sets And Accessories and US home infusion growth among seniors creates major opportunity for Iv Tubing Sets And Accessories

The rapidly expanding healthcare infrastructure within India is particularly focused on the improvement of critical care facilities, however, IV tubes and associated accessories continue to be a largely underdeveloped market, especially outside the larger cities. The need for intravenous products will be driven by the increasing patient volume in the hospitals emergency department and the ICU. By 2030 it is predicted that global sales of primary IV tubing sets will rise from $0.66 billion to $0.87 billion, providing opportunities for those who manufacture the product to localise production, secure contracts with hospitals by negotiating a better price and to tie up with hospital groups for long term deals.
The US home infusion therapy industry is placing greater emphasis on treating conditions such as heart failure and cancer and long term antibiotic treatments at home. This segment covers IV extension sets and primary IV sets which are compatible with portable infusion pumps and also solutions for infection control. By 2030, it is predicted that IV extension sets will rise from $0.19 billion to $0.27 billion globally. Companies which supply user friendly IV extension sets and which provide training for caregivers are likely to meet an underserved need in this market which is driven by the reimbursement of medical treatment.
04

Challenge: High Competition and Pricing Pressures

The market for IV tubing sets and accessories is fiercely competitive as many companies compete for a piece of the pie in this industry space. This intense competition leads to pricing challenges that can pose obstacles, for smaller or emerging players looking to carve out a niche successfully.

Supply Chain Landscape

1

Raw Materials

Baxter InternationalNipro
2

IV Set Manufacturing

B. Braun Medical Inc.Polymedicure
3

Accessory Assembly

Zyno Medical LLCICU Medical
4

Clinical End Use

HospitalsAmbulatory Surgical CentersHome Healthcare
IV Tubing Sets And Accessories - Supply Chain

Use Cases of IV Tubing Sets And Accessories in Medical Infusion Therapy & Pharmaceutical Drug Delivery

Medical Infusion Therapy : IV tubing sets and accessories are frequently utilized in medical infusion therapy to accurately administer vital medical fluids and medications to patients while ensuring their well being and convenience are prioritized in the process of infusion rate precision. B. Braun Melsungen AG and Becton, Dickinson and Company are contributors, in this field.
Pharmaceutical Drug Delivery : IV tubing sets play a role in the pharmaceutical industry by enabling precise and prompt drug delivery directly into the bloodstream. By administering drugs it helps minimize wastage and enhances absorption efficiency. This approach offers advantages for vital medications that can save lives. Baxter International Inc. Smith Medical have shown considerable progress, in this field.
Clinical Nutrition : IV tubing sets and accessories play a role in clinical nutrition for delivering parenteral nutrition to patients who cannot eat orally or, through a feeding tube specifically tailored nutritional formulas can be administered using these IV supplies Fresenius SE & Co KGaA and ICU Medical Inc are leading innovators in this region creating secure and efficient solutions to address intricate nutritional requirements

Recent Developments

The worldwide market for IV Tubings and Accessories has experienced expansion in the past years due to various factors such as the rise in chronic illnesses prevalence and the advancement and acceptance of cutting edge medical technologies alongside the escalating demand for better healthcare services. A notable trend, in this market is the rising utilization of IV tubing sets.

December 2024 : Becton Dickinson and Company introduced IV tubing sets with antimicrobial properties to improve patient safety, in healthcare environments by reducing the risk of infections.
October 2024 : Smiths Medical introduced their upgraded Saflo IV tubing accessories aimed at reducing medication infusion complications
August 2024 : A new friendly range of IV tubing sets has been introduced by B. Braun Melsungen AG as part of their Green Initiative; it features a significant reduction, in plastic usage and the use of biodegradable materials.

Impact of Industry Transitions on the IV Tubing Sets And Accessories Market

As a core segment of the Other Healthcare industry, the IV Tubing Sets And Accessories market develops in line with broader industry shifts. Over recent years, transitions such as Shift towards Disposable IV Tubing Sets and Adoption of Technological Innovations have redefined priorities across the Other Healthcare sector, influencing how the IV Tubing Sets And Accessories market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift towards Disposable IV Tubing Sets

The IV tubing sets and accessories sector is in the process of a shift towards the IV tubings which are disposable in nature. This is because there is an increasing concern among healthcare professionals over cross infection, a reduction in cross contamination and stronger patient protection policies. At present the sectors growth rate stands at 6.3% but firms within the industry are actively working towards increasing this with the marketing of single use IV tubing as well as the relevant accessories. Some sixty five million dollars in investments are set to be committed to this strategy by the year 2030, enhancing and increasing production capability, and also stimulating new and innovative products for disposable medical products. The reallocation of resources reflects a change in competitive market positioning where suppliers with low cost products for infection control IV equipment will capture market growth and establish long term standards in the market.
02

Adoption of Technological Innovations

The industry for IV tubing sets and related accessories is undergoing significant changes with the adoption of the latest technologies.